2'-C-cyano-2'-deoxy-1-arabinofuranosyl-N(4)-palmitoylcytosine,
CNDAC cpd,
CS-682,
CYC 682,
CYC-682,
sapacitabine,
Sapacitabine,
151823-14-2,
CS-682,
UNII-W335P73C3L,
CYC682,
CS 682,
CYC-682,
W335P73C3L,
N-(1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl)hexadecanamide,
CS682,
Hexadecanamide, N-(1-(2-cyano-2-deoxy-beta-D-arabinofuranosyl)-1,2-dihydro-2-oxo-4-pyrimidinyl)-,
N-[1-[(2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-2-oxopyrimidin-4-yl]hexadecanamide,
Sapacitabine [USAN:INN],
CYC 682,
PCNDAC,
AC1L4BGC,
Sapacitabine (CYC682),
Sapacitabine (USAN/INN),
SCHEMBL711854,
CHEMBL2105681,
DTXSID90164887,
LBGFKUUHOPIEMA-PEARBKPGSA-N,
EX-A1617,
CS0045,
ZINC14263648,
SB17112,
HY-16445,
LS-183264,
CS-0006340,
D09722,
Z-3189,
823S142,
1-(2-deoxy-2-cyano-|A-d-arabinofuranosyl)cytosine,
1-(2-c-cyano-2-deoxy-|A-d-arabino-pentofuranosyl)cytosine,
1-(2-cyano-2-deoxy-|A-d-arabinofuranosyl)-4-(palmitoylamino)pyrimidin-2(1h)-one,sapacitabine,
4-amino-1-[(3|A-cyano-4|A-hydroxy-5|A-hydroxymethyltetrahydrofuran)-2|A-yl]pyrimidin-2(1h)-one,
N-(1-((2R,3S,4S,5R)-3-cyano-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2-oxo-1,2-dihydropyrimidin-4-yl)palmitamide,
CNDAC,
D0D4RF,
C26H42N4O5,
CID153970,
A12801,